A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker’s Bureau - Boston Scientific Corporation
- Consultant Fee/Honoraria/Speaker's Bureau - Shockwave Medical